Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients

DOI: 10.4274/tjh.galenos.2019.2018.0393

Keywords: Hemophilia, Factor replacement therapy, Extended half-life products, Laboratory assays, Pharmacokinetics, Quality of life

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text